In conversation with Cristiana Campa: modernizing vaccine specifications and advancing risk-based quality frameworks

Cristiana Campa examines how advances in analytical characterization and risk-based regulatory frameworks are redefining vaccine development and manufacturing. Drawing on her work revising the ICH Q6 guideline on specifications, she discusses the role of harmonized, science-driven standards in supporting vaccine quality, global development pathways, and emerging modalities such as therapeutic and mRNA-based vaccines.

Cristiana Campa, CMC External Intelligence Lead, Vaccines Technical R&D, MDS, GSK, UK

Please enter your email to access content Read now